TSX-V:NPTH - TSX Venture Exchange - CA64133P1009 - Common Stock - Currency: CAD
TSX-V:NPTH (2/21/2025, 7:00:00 PM)
0.2
-0.01 (-4.76%)
The current stock price of NPTH.CA is 0.2 CAD. In the past month the price increased by 2.56%. In the past year, price increased by 17.65%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
WELL-DB.CA | WELL HEALTH TECHNOLOGIES | 837.5 | 25.12B | ||
AND.CA | ANDLAUER HEALTHCARE GROUP IN | 28.73 | 1.78B | ||
WELL.CA | WELL HEALTH TECHNOLOGIES COR | 51 | 1.53B | ||
DNTL.CA | DENTALCORP HOLDINGS LTD | 28.78 | 1.46B | ||
AIDX.CA | HEALWELL AI INC | N/A | 260.00M | ||
QIPT.CA | QUIPT HOME MEDICAL CORP | N/A | 151.88M | ||
KDA.CA | KDA GROUP INC | N/A | 54.49M | ||
NLH.CA | NOVA LEAP HEALTH CORP | N/A | 22.70M | ||
ARC.CA | ARCPOINT INC | N/A | 11.81M | ||
PHA.CA | PREMIER HEALTH OF AMERICA IN | N/A | 9.99M | ||
JNH.CA | JACK NATHAN MEDICAL CORP | N/A | 2.18M |
NeuPath Health, Inc. operates as a healthcare services company that provides chronic pain management services. The company is headquartered in Mississauga, Ontario and currently employs 156 full-time employees. The company went IPO on 2019-12-03. The company operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. The company also provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical and biotechnology companies. The firm's health care providers cover a range of specialties and include physiatrists, neurologists, anesthesiologists, orthopedic surgeons, general practitioners with specialized training in chronic pain, as well as medication management physicians, athletic therapists, and others.
NEUPATH HEALTH INC
9-6400 Millcreek Drive
Mississauga ONTARIO L5N 3E7 CA
CEO: Grant Connelly
Employees: 156
Company Website: https://www.neupath.com/
Investor Relations: http://www.neupath.com/investors
Phone: 18002653429
The current stock price of NPTH.CA is 0.2 CAD. The price decreased by -4.76% in the last trading session.
The exchange symbol of NEUPATH HEALTH INC is NPTH and it is listed on the TSX Venture Exchange exchange.
NPTH.CA stock is listed on the TSX Venture Exchange exchange.
NEUPATH HEALTH INC (NPTH.CA) has a market capitalization of 11.24M CAD. This makes NPTH.CA a Nano Cap stock.
NEUPATH HEALTH INC (NPTH.CA) currently has 156 employees.
NEUPATH HEALTH INC (NPTH.CA) has a support level at 0.16 and a resistance level at 0.22. Check the full technical report for a detailed analysis of NPTH.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NPTH.CA does not pay a dividend.
NEUPATH HEALTH INC (NPTH.CA) will report earnings on 2025-03-13.
NEUPATH HEALTH INC (NPTH.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).
ChartMill assigns a technical rating of 7 / 10 to NPTH.CA. When comparing the yearly performance of all stocks, NPTH.CA is one of the better performing stocks in the market, outperforming 79.7% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to NPTH.CA. NPTH.CA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months NPTH.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS increased by 52.27% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -2.05% | ||
ROE | -3.92% | ||
Debt/Equity | 0.49 |
ChartMill assigns a Buy % Consensus number of 80% to NPTH.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.